Ozempic

Ozempic is a prescription medication developed by Novo Nordisk used to treat type 2 diabetes and, off-label, for weight management. It is a GLP-1 receptor agonist that helps control blood sugar and reduce appetite.

Why it’s in the news: It is in the news due to widespread use for weight loss, leading to supply shortages, side effects like 'Ozempic face,' and concerns about its manufacturer's future market dominance.

Latest on Ozempic

• Taking Ozempic and worried about vision loss? This test can help you understand your risk.
• Novo Nordisk’s stock tumbles as doubts persist about Ozempic maker’s goals for 2030
• K-Beauty wants to fix the ‘Ozempic face’ problem
• South Korean biotech bets on donated human fat product to fix ‘Ozempic face’
• How Ozempic maker Novo Nordisk blew its lead in GLP-1 weight-loss drugs. Can Europe compete in the high-stakes global economy?
• Are Ozempic and other weight loss drugs also longevity drugs? Here's what early research suggests

Connections

6 entities linked to Ozempic across the news graph.